FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1265-1266 October 21, 1993 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The report in this issue of the Journal by Sibai and colleagues¹ highlights the search for a treatment to alter the incidence of preeclampsia. Hypertensive disorders complicate 10 to 12 percent of the 3.5 million pregnancies each year in the United States. The majority of the women with such disorders have preeclampsia (defined as hypertension and proteinuria beginning after 20 weeks of gestation), making preeclampsia the most common medical disease in pregnancy¹. Although 85 percent of women with preeclampsia are nulliparous, multiparous women who have chronic hypertension antedating pregnancy have a 25 percent risk of superimposed preeclampsia. In developed . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Moya, F. R., Germain, A., Sibai, B. M. (1994). Prevention of Preeclampsia with Low-Dose Aspirin. NEJM 330: 794-795 [Full Text]  
• (1993). DOES ASPIRIN PREVENT PREECLAMPSIA IN HEALTHY WOMEN?. JWatch General 1993: 1-1 [Full Text]